XBI - SPDR S&P Biotech ETF -  [ ]

Ticker Details
SPDR S&P Biotech ETF
The investment seeks to provide investment results that, before fees and expenses, correspond generally to the total return performance of the S&P Biotechnology Select Industry Index derived from the biotechnology segment of a U.S. total market composite index. In seeking to track the performance of the S&P Biotechnology Select Industry Index (the "index"), the fund employs a sampling strategy. It generally invests substantially all, but at least 80%, of its total assets in the securities comprising the index. The index represents the biotechnology segment of the S&P Total Market Index ("S&P TMI"). The fund is non-diversified.
IPO Date: February 6, 2006
Sector: Healthcare
Industry: Biotech
Activated in VL: True
Average Daily Range
Avg Daily Range: $1.23 | 1.35%
Avg Daily Range (30 D): $2.21 | 1.58%
Avg Daily Range (90 D): $1.99 | 1.51%
Institutional Daily Volume
Avg Daily Volume: 4.23M
Avg Daily Volume (30 D): 9.15M
Avg Daily Volume (90 D): 8.93M
Trade Size
Avg Trade Size (Sh.): 114
Avg Trade Size (Sh.) (30 D): 82
Avg Trade Size (Sh.) (90 D): 79
Institutional Trades
Total Institutional Trades: 32,026
Avg Institutional Trade: $5.57M
Avg Institutional Trade (30 D): $9.15M
Avg Institutional Trade (90 D): $6.82M
Avg Institutional Trade Volume: .08M
Avg Institutional Trades (Per Day): 8
Market Closing Trades
Avg Closing Trade: $17.97M
Avg Closing Trade (30 D): $31.17M
Avg Closing Trade (90 D): $28.71M
Avg Closing Volume: 201.19K
 
News
Jul 5, 2026 @ 1:15 PM
Fidelity Health Care vs. State Street Biotech: Whi...
Source: Erin Kennedy
Jun 23, 2026 @ 3:41 PM
Healthcare: Pockets of Alpha
Source: Ed Yardeni
May 28, 2026 @ 12:07 PM
VHT vs. XBI: Vanguard Health Care ETF Tops SPDR Bi...
Source: Jake Lerch
May 15, 2026 @ 2:18 PM
2 Ways to Play the Big Pharma Patent Cliff
Source: Nathan Reiff
Mar 19, 2026 @ 7:03 PM
Is Relay Therapeutics a Buy in 2026? One Instituti...
Source: Andy Gould
Splits
Sep 11, 2015 3:1
Jan 01, 2015 3:1